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INTRODUCTION 51
In humans, one of the primary thermoregulatory responses to increased core and skin 52 temperatures is sweating from eccrine sweat glands. Several conditions, such as aging, diabetes, 53 multiple sclerosis, skin grafting, prolonged bed rest, and some variations of heat stroke (1, 7, 9-54 11, 13, 18, 37) are associated with diminished sweating, and thereby have the potential to reduce 55 heat tolerance. It is important to understand neural and non-neural factors that modulate the 56 sweating response to more fully understand thermoregulatory abnormalities in these and other 57 conditions. 58
Thermoregulatory sweating is primarily initiated by increased internal (core) and skin 59 temperatures, with the associated afferent neural signals integrated at the hypothalamus (31, 33) . 60
Initially, sweating occurs via stimulation of sweat glands upon neurotransmitter release from 61 sympathetic cholinergic neurons, but periglandular conditions can modulate the sweating 62 response. For example, changes in local skin temperature can modify sweat rate (SR), as 63 evidenced by accentuated sweating with local skin heating (20, (25) (26) (27) 29) and attenuated 64 sweating with local skin cooling (2, 8, 22, 25, 26) . The mechanism for attenuation of sweating 65 by local skin cooling remains unclear but is likely peripheral in nature since attenuated sweating 66 has been demonstrated at locally cooled sites despite continually increasing core body 67 temperature and stable mean whole-body skin temperature (26). Hence, local temperature may 68 directly affect sweat glands and/or neurotransmitter release from sudorific neurons. 69
In addition to decreasing regional skin temperature, local cooling also reduces skin blood 70 flow (3, 15, 16) . Occluding the arterial supply of a limb during either heat stress or 71 administration of sudorific drugs decreases SR distal to the occlusion (4, 5, 12, 20, 29) . 72 However, it is unknown whether the magnitude of the reduction in skin blood flow associated 73
Local cooling, skin blood flow, and sweat rate 3 with local cooling, which is much less than that relative to complete ischemia, likewise impairs 74 sweating responsiveness. Given these prior observations, the purpose of the present study was to 75 test the hypotheses that 1) decreased skin blood flow, independent of local temperature, and 2) 76 decreased local temperature, independent of skin blood flow, attenuate sweating during whole-77 body heat stress. 78
79

METHODS 80
Subjects 81
Subjects were non-smokers and were free of any known cardiovascular, metabolic, or 82 neurological diseases. Seven men and 1 woman completed Protocol I and 6 men and 2 women 83 completed Protocol II. Their mean (± SD) age, height, and weight were 38 ± 10 y, 175.9 ± 7.5 84 cm, and 72.2 ± 13.5 kg for Protocol I and 31 ± 12 y, 173.8 ± 7.0 cm, and 69. After this initial phase of instrumentation, subjects donned a tube-lined water perfusion suit 101 (Med-Eng, Ottawa, Canada) over shorts (or over shorts and a sports bra for the women). The 102 suit covered the entire body except for the feet, hands, face, head, and one forearm. min from the start of NE administration), the water perfusing the suit was switched to 48 °C to 131 elicit a whole-body heat stress. Each microdialysis probe was perfused continuously with its 132 respective solution (i.e., NE for the experimental sites and Ringer's solution for the control sites) 133 throughout the heat stress. The duration of whole-body heating was based on achieving an 134 increase in T c of ~ 1 °C. Subjects were then cooled by decreasing the temperature of water 135 perfusing the suit while instrumentation was removed. 136
Procedures for Protocol II 137
Similar to Protocol I, throughout instrumentation and while hyperemia associated with 138 microdialysis probe placement subsided, 34 °C water was perfused through the suit. Once 139 hyperemia subsided and skin blood flow was stable, 28 mM sodium nitroprusside (SNP; a nitric 140 oxide donor) was administered to all microdialysis sites to elicit maximal cutaneous vasodilation 141
Local cooling, skin blood flow, and sweat rate 6 (17, 24, 38) . After 20 min, 2 microdialysis sites were cooled to 20 °C while the other 2 sites 142 remained at 34 °C. Once skin blood flow and temperature were stable at the locally-cooled sites, 143 the water temperature perfusing the suit was increased to 48 °C to elicit a whole-body heat stress 144 like in Protocol I. All sites continued to receive 28 mM SNP throughout the heat stress. As in 145
Protocol I, whole-body heating was administered until achieving an increase in T c of ~ 1 °C. 146
Subjects were then cooled by switching the water perfusing the suit to a lower temperature while 147 instrumentation was removed. 148
Data Analysis 149
In Protocol I, in order to more robustly assess the effect of the difference in skin blood 150 flow on sweat rate, data from the single NE site and the single control site with the greatest 151 difference in skin blood flow were statistically analyzed. In Protocol II, in order to more 152 robustly assess the effect of the difference in local temperature on sweat rate, data from the 153 single locally-cooled site and the single control site with the most similar skin blood flows were 154 statistically analyzed. Data for both protocols were statistically analyzed in the same manner. 155 Data were acquired continuously at a sampling rate of 50 Hz using a data acquisition system 156 (Biopac, Santa Barbara, CA). SR and temperature (i.e., T -b , T -sk , T c ) data were averaged every 30 157 s during heat stress. Changes in temperature variables before heating compared to the end of the 158 heat stress were analyzed using one-tailed paired samples t-tests. The onset of sweating for each 159 site was determined by an experienced investigator blinded to the sites (i.e., Protocol I: NE and 160 control; Protocol II: cool and control) by visually inspecting SR graphed relative to time. The T -b 161 at the indicated time for the onset of sweating was then identified and reported as the temperature 162 threshold for the onset of sweating. This value was compared between sites using a one-tailed 163 paired samples t-test. The T -b at the plateau in the SR response, or at the final T -b if a plateau did 164
Local cooling, skin blood flow, and sweat rate 7 not occur, was identified. The slope of the SR:T -b relationship was calculated using linear 165 regression of all data points between the onset of sweating and end of heat stress (or plateau of 166 SR if applicable). This slope was compared between sites using a one-tailed paired samples t-167 test. Additionally, sweat rate at each microdialysis site, across changes in T c, was analyzed using 168 a two-way (site × ΔT c in 0.1 °C increments) repeated measures analysis of variance (ANOVA). 169
The Greenhouse-Geisser adjustment to degrees of freedom was utilized for all ANOVA tests. The primary finding from this study is that decreased skin blood flow and decreased local 225 skin temperature each independently diminish the elevation of SR relative to the elevation in T  -b   226 induced by whole-body heat stress. The onset of sweating was not affected by decreased skin 227 blood flow and was only marginally affected by decreased local temperature. For both protocols, 228 the neural drive for sweating was the same between sites. Therefore, these findings suggest that 229 attenuated SR during local cooling observed in previous studies (20, 26, 29) was likely due to 230 decreased skin blood flow, decreased local temperature, or some combination of these effects. 231
Local cooling, skin blood flow, and sweat rate 10 The present findings are consistent with findings of reduced sweating during decreased 232 skin blood flow via ischemia (4, 5, 12, 20, 29) or secondary to decreased local skin temperature 233 (20, 26, 29) . Despite these similarities, to our knowledge the present protocols are the first to 234 independently manipulate skin blood flow and local skin temperature while simultaneously 235 observing the effects on local sweat rate. The mechanism for the reduction in sweating 236 associated with ischemia is likely different relative to reduced skin blood flow when local 237 temperature is decreased. Mitigation of sweating during ischemia is proposed to result from an 238 interruption of nerve transmission across the neuroglandular junction secondary to inadequate 239 oxygen tension necessary for transmitter synthesis (12). In the present study it is unlikely that 240 decreased skin blood flow at the NE site resulted in inadequate oxygen tension necessary for 241 transmitter synthesis since, in the presence of NE, the skin still receives nutritive blood flow, just 242 at a lower level, as opposed to ischemia in which there is a complete absence of blood flow to the 243 skin. Moreover, decreased skin blood flow via adrenergic vasoconstriction, similar to the present 244 study, mitigates sweating to administration of exogenous acetylcholine (thus bypassing the need 245 for transmitter synthesis since acetylcholine can bind directly to muscarinic receptors on sweat 246 glands) (6). 247
In Protocol I, even though skin blood flow averaged ~66 perfusion units lower at the NE 248 site relative to the control site, the threshold for the onset of sweating was similar between sites 249 when expressed relative to time (data not shown) or to increased T -b from pre-heat stress, which 250 further refutes the idea that decreased skin blood flow at the NE site impairs neurotransmitter 251 synthesis. In contrast, the slope of the SR:T -b relation was ~50% lower at the NE site during the 252 remainder of heat stress (Figures 1 and 3 ). Although speculative, a possible explanation for the 253 observed findings may be that substances ordinarily released as a result of increased shear stress 254 Local cooling, skin blood flow, and sweat rate 11 associated with high skin blood flow [e.g., nitric oxide (21, 30)] that have been shown to amplify 255 sweating (19, 36) were not present in the same proportions at the NE site relative to the control 256 site. In support of this hypothesis, inhibition of nitric oxide attenuates sweating in horses and 257 humans (19, 23, 36) . We speculate that when differences in skin blood flow were smaller (such 258 as early in heat stress at the onset of sweating), shear stress-mediated release of nitric oxide (if 259 present in the skin) was low resulting in sweating not being different between sites, but as heat 260 stress progressed and differences in skin blood flow became larger, perhaps more nitric oxide 261 was released at the control site thereby sensitizing sweat glands. 262
In light of the potential effect of shear stress-induced nitric oxide release in altering SR 263 sensitivity, it is noteworthy that in Protocol II SR sensitivity was depressed when local 264 temperature was decreased but when skin blood flow, and nitric oxide availability (via 265 continuous SNP administration) were similar between sites. It may be that local cooling 266 mitigates sudorific neurotransmitter release, as has been suggested by others (25, 26, 33) . 267
Alternatively, given that local warming sensitizes sweat glands (2, 27, 28), it may be that local 268 cooling results in the opposite effect, i.e., desensitization of receptors on sweat glands. 269
Regardless of the possible mechanisms, the methods employed in previous studies investigating 270 sweating responses to skin cooling do not permit the independent evaluation of blood flow and 271 local skin temperature on sweating, given decreases in skin blood flow secondary to local 272 cooling were not controlled in those studies (2, 8, 20, 22, 25, 26) . 273
It might be argued that in Protocol I NE itself could attenuate sweating by an 274 unrecognized mechanism. However, NE and other adrenergic compounds stimulate sweating by 275 binding to adrenergic receptors on sweat glands (6, 14, 31, 32) , so any potential direct effect of 276 NE on sweat glands would have likely been stimulatory rather than inhibitory. Furthermore, Collins et al. (6) observed that when epinephrine was combined with a local injection of 278 acetylcholine, SR was depressed but only in the presence of vasoconstriction, which, in light of 279 the findings from Protocol I, suggests that such sweating depression could result from 280 vasoconstriction, not from a direct effect of NE. Since NE per se has not been shown to 281 attenuate sweating in the absence of vasoconstriction, it is unlikely that the attenuation of 282 sweating at the NE site in the current study was due to a direct effect of NE, independent of the 283 cutaneous vasculature. 284
A perceived limitation of the current study may be the use of T -b in the calculation of SR 285 sensitivity (i.e., slope) instead of other measures of core body temperature such as esophageal or 286 intestinal temperature. It is recognized that previous studies on this topic (26) In summary, decreased skin blood flow and decreased local skin temperature each 296 independently diminish SR sensitivity during passive heat stress in humans. The precise 297 mechanisms for this modulation cannot be determined from the obtained data, but it is postulated 298 that reduced shear-stress mediated nitric oxide release secondary to reduced skin blood flow, as 299 well as direct effects of decreased local temperature on sweat gland receptors or neurotransmitter 300
Local cooling, skin blood flow, and sweat rate 13 release, may be responsible. However, it should be noted that shear-stress mediated nitric oxide 301 release in human skin is controversial and unclearly delineated (38) . Accordingly, further 302 studies are warranted to evaluate the potential mechanisms responsible for the observed findings. 303 304 
FIGURE LEGENDS 414
